About Novocure
Novocure is a company based in Haifa (Israel) founded in 2000. It operates as a HealthTech. Novocure has raised $10 million across 3 funding rounds from investors including Pfizer Venture Investments, Johnson & Johnson Innovation – JJDC and Index Ventures. The company has 1,490 employees as of December 31, 2024. Novocure offers products and services including Optune Gio and Optune Lua. Novocure operates in a competitive market with competitors including Ablatus Therapeutics, QV Bioelectronics, Mirai Medical, Autem Therapeutics and Pulse Biosciences, among others.
- Headquarter Haifa, Israel
- Employees 1490 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novocure Limited
-
Annual Revenue
$605.22 M18.82as on Dec 31, 2024
-
Net Profit
$-168.63 M18.55as on Dec 31, 2024
-
EBITDA
$-156.3 M27.36as on Dec 31, 2024
-
Total Equity Funding
$10 M (USD)
in 3 rounds
-
Latest Funding Round
$500 M (USD), Post-IPO
Nov 02, 2020
-
Investors
Pfizer Venture Investments
& 2 more
-
Employee Count
1490
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Novocure
Novocure is a publicly listed company on the NASDAQ with ticker symbol NVCR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Novocure
Novocure offers a comprehensive portfolio of products and services, including Optune Gio and Optune Lua. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A device for treating aggressive cancer with TTFields.
A therapy device using TTFields for cancer treatment.
Unlock access to complete
Unlock access to complete
Software Development Team
58 people
Senior Team
23 people
Leadership Team
20 people
Operations Team
20 people
Sales and Marketing
19 people
Device Team
19 people
Finance and Accounting
15 people
Legal and Compliance
13 people
Unlock access to complete
Funding Insights of Novocure
Novocure has successfully raised a total of $10M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $500 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $500.0M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Post-IPO - Novocure | Valuation |
investors |
|
| Jun, 2010 | Amount | Series A - Novocure | Valuation | Pfizer Venture Investments , Johnson & Johnson Innovation – JJDC |
|
| Sep, 2009 | Amount | Series A - Novocure | Valuation | Johnson & Johnson Innovation – JJDC , Pfizer Venture Investments |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Novocure
Novocure has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Pfizer Venture Investments, Johnson & Johnson Innovation – JJDC and Index Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is focused on healthcare by Pfizer's investment arm.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology startups and entrepreneurs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Novocure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Novocure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novocure Comparisons
Competitors of Novocure
Novocure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ablatus Therapeutics, QV Bioelectronics, Mirai Medical, Autem Therapeutics and Pulse Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops innovative devices for bimodal electric tissue ablation.
|
|
| domain | founded_year | HQ Location |
Electrotherapy devices for brain tumor treatment are manufactured.
|
|
| domain | founded_year | HQ Location |
Mirai Medical is focused on transforming gastrointestinal disease treatment.
|
|
| domain | founded_year | HQ Location |
Bioelectric platforms for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Nano-Pulse Electro-Signaling technology is developed for targeted cellular disruption.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novocure
Frequently Asked Questions about Novocure
When was Novocure founded?
Novocure was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Where is Novocure located?
Novocure is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Is Novocure a funded company?
Novocure is a funded company, having raised a total of $10M across 3 funding rounds to date.
How many employees does Novocure have?
As of Dec 31, 2024, the latest employee count at Novocure is 1,490.
What is the annual revenue of Novocure?
Annual revenue of Novocure is $605.22M as on Dec 31, 2024.
What does Novocure do?
Novocure is a global oncology company dedicated to extending survival in patients with some of the most aggressive forms of cancer. The company specializes in Tumor Treating Fields (TTFields) therapy, a novel approach to cancer treatment. Products like Optune Gio and Optune Lua are developed to target specific cancer types. Research and clinical trials, such as the PANOVA-3 trial for pancreatic cancer, are conducted to advance therapeutic solutions. Operations span multiple regions including North America, Europe, and Asia. Collaboration with patients and healthcare professionals is emphasized to improve outcomes in oncology.
Who are the top competitors of Novocure?
Novocure's top competitors include QV Bioelectronics, Pulse Biosciences and Autem Therapeutics.
What products or services does Novocure offer?
Novocure offers Optune Gio and Optune Lua.
Is Novocure publicly traded?
Yes, Novocure is publicly traded on NASDAQ under the ticker symbol NVCR.
Who are Novocure's investors?
Novocure has 3 investors. Key investors include Pfizer Venture Investments, Johnson & Johnson Innovation – JJDC, and Index Ventures.
What is Novocure's ticker symbol?
The ticker symbol of Novocure is NVCR on NASDAQ.